Your browser doesn't support javascript.
loading
N-terminal pro-brain natriuretic peptide is a prognostic marker for response to intensive chemotherapy, early death, and overall survival in acute myeloid leukemia.
Graf, Irene; Greiner, Georg; Marculescu, Rodrig; Gleixner, Karoline V; Herndlhofer, Susanne; Stefanzl, Gabriele; Knoebl, Paul; Jäger, Ulrich; Hauswirth, Alexander; Schwarzinger, Ilse; Thalhammer, Renate; Kundi, Michael; Hoermann, Gregor; Mitterbauer-Hohendanner, Gerlinde; Valent, Peter; Sperr, Wolfgang R.
Afiliação
  • Graf I; Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
  • Greiner G; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Marculescu R; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Gleixner KV; Ihr Labor, Medical Diagnostic Laboratories, Vienna, Austria.
  • Herndlhofer S; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Stefanzl G; Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
  • Knoebl P; Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
  • Jäger U; Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
  • Hauswirth A; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Schwarzinger I; Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
  • Thalhammer R; Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
  • Kundi M; Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
  • Hoermann G; Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
  • Mitterbauer-Hohendanner G; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Valent P; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Sperr WR; Institute of Environmental Health, Medical University of Vienna, Vienna, Austria.
Am J Hematol ; 98(2): 290-299, 2023 02.
Article em En | MEDLINE | ID: mdl-36588398

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Cardiopatias Tipo de estudo: Prognostic_studies Limite: Humans / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Áustria

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Cardiopatias Tipo de estudo: Prognostic_studies Limite: Humans / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Áustria